# FDA Inspection 1197334 - Dr. Brandon Essink - January 27, 2023

Source: https://www.keypedia.com/records/fda_inspections/dr-brandon-essink/38892b02-872d-4bb7-a688-93db7c282667
Source feed: FDA_Inspections

> FDA Inspection 1197334 for Dr. Brandon Essink on January 27, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1197334
- Company Name: Dr. Brandon Essink
- Inspection Date: 2023-01-27
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1046892 - 2018-03-15](https://www.keypedia.com/records/fda_inspections/dr-brandon-essink/dfc9d6ea-2325-4d18-90d8-5dec907e8a52)
- [FDA Inspection 1044837 - 2018-02-01](https://www.keypedia.com/records/fda_inspections/dr-brandon-essink/33caef93-330a-48e9-b0fc-a0e275cf1db4)
- [FDA Inspection 769729 - 2012-02-24](https://www.keypedia.com/records/fda_inspections/dr-brandon-essink/f381f72f-9fac-42fa-9738-4b6fe04460cb)

Company: https://www.keypedia.com/companies/dr-brandon-essink/dfb3a883-bce7-4681-ae26-2e58163ce062

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d